# Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-plus-cabozantinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Toni K. Choueiri,Thomas Powles,Mauricio Burotto,Bernard Escudier,María T. Bourlon,Bogdan Żurawski,Víctor Manuel Oyervides-Juárez,James J. Hsieh,Umberto Basso,Amishi Y. Shah,Cristina Suárez,Alketa Hamzaj,Jeffrey C. Goh,Carlos H. Barrios,Martin Eduardo Richardet,Camillo Porta,Rubén Dario Kowalyszyn,Juan P. Feregrino,Jakub Żołnierek,David Pook,Elizabeth R. Kessler,Yoshihiko Tomita,Ryuichi Mizuno,Jens Bedke,Joshua Zhang,Matthew Maurer,Burçin Şimşek,Flavia Ejzykowicz,Gisela Schwab,Andrea B. Apolo,Robert J. Motzer |
| Citations | 1,773 |
| DOI | 10.1056/nejmoa2026982 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa2026982?articleTools=true |
| OpenAlex ID | https://openalex.org/W3134949580 |
| PMID | 33657295 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Toni K. Choueiri](https://scholariq.org/researchers/toni-k-choueiri/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.